Results 71 to 80 of about 2,292 (152)

[On the mass of microbic substance in typhoid-paratyphoid vaccine].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 2010
V L, TROICKY, R A, WEGER
openaire   +1 more source

Effective strategies for typhoid conjugate vaccine delivery: Health and economic insights from the 2015 Kampala outbreak. [PDF]

PLoS Negl Trop Dis
Lee Y, Salonga PKN, Son C, Jang G, Koh DH, Kim JH, Lee H.   +6 more
europepmc   +1 more source

[ALUMINUM HYDROXIDE AS AN ADSORBENT FOR TYPHOID-PARATYPHOID VACCINES].

Medycyna doswiadczalna i mikrobiologia, 1996
W, WOJCIAK, E, WOLSKA
openaire   +1 more source

Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.

Vaccine
Ibarz-Pavon AB, Bielsky MC, Bose R, Cavaleri M, Crump JA, Hombach J, Kaslow DC, Khaman F, MacLennan CA, Mehring-LeDoare K, Pollard AJ, Quadri F, John J, Wilder-Smith A.   +13 more
europepmc   +1 more source

Epidemiologic trends, diagnostic limitations, and public health challenges of enteric fever in sub-Saharan Africa: A narrative review. [PDF]

IJID Reg
Ofori EK, Kpabitey IL, Aidoo NE, Amponsah SK.   +3 more
europepmc   +1 more source

XDR typhoid in Pakistan: A threat to global health security and a wake-up call for antimicrobial stewardship. [PDF]

PLoS Negl Trop Dis
Abdullah MA, Shaikh BT, Ashraf M, Khan SA.   +3 more
europepmc   +1 more source

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants. [PDF]

Hum Vaccin Immunother
Mankar SV, Patel C, Chavan A, Modi R, Sarangi L, Tripathi VN, Dash DK, Narayan JP, Bandgar S, Kumar NR, Gill VK, Kakkar MK, Mitra M, Daultani P, Mittal R, Maithal K, Kansagra K, Parmar DV, Dutta T, Mahajan M, Desai S.   +20 more
europepmc   +1 more source

Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants. [PDF]

Viruses
Rao SN, Ambike D, Patil M, Mankar SV, Verma N, Hanumante N, Sarangi L, Mitra M, Preeti G, Deshmukh BJ, Nanoti G, Faridi MMA, Daultani P, Mittal R, Maithal K, Kansagra K, Parmar DV, Kunnathamman R, Elaiyaraja M, Dutta T, Mahajan M, Desai S.   +21 more
europepmc   +1 more source

False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19. [PDF]

Front Med (Lausanne)
Moya-Salazar J, Ciprian LY, Rojas-Zumaran V, Moya-Salazar B, Goicochea-Palomino EA, Contreras-Pulache H.   +5 more
europepmc   +1 more source

Multivalent vaccines for invasive <i>Salmonella</i> disease: need, rationale, and immunological foundations. [PDF]

Infect Immun
Mastroeni P, Rossi O, Micoli F.
europepmc   +1 more source